Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Thursday, July 2

POS E T B 4

42137 Increasing trends in the prevalence of HIV-infection among blood
donors in West Bengal
Nemai Bhattacharya*; D.K. Neogi; T. Chakra Borti; P. Banerjee, India
42138 Slow seroconversion of HIV in a severely ill patient
Chetan Oberai*; S.K. Hira; H.M. Gharpure; M.M. Kura, India
42139 Seroepidemiological prevalence of HIV in Southeastern Asian
and South Asian recruiters to Saudi Arabia
Sami E. Fathalla*; I.H. Al-Sheikh, Saudi Arabia
42140 The course of HIV RNA levels over 17 years of HIV-infection in a cohort
of haemophilic men
Caroline Sabin*; H. Devereux; A.N. Phillips; A.M. Hill; CA. Lee; C Loveday,
UK
42141 Plasma and genital tract viral load and STDs in early HIV-infection
Connie Celum*; K. Mayer; S. Holte; D. Dondero; S.P. Buchibinder;
J. Douglas; H.W. Sheppard, USA
42142 Evaluation of laboratory performance in determining HIV-1 RNA levels
present in CDC performance evaluation samples
Sharon Blumer*; W.O. Schalla; T.L. Hearn; R.J. Fehd, USA
42143 Multi-center evaluation of the ultra sensitive Roche amplicor HIV-1
MonitorT assay
James W. Bremer*; D. Brambilla; C Michels; B. Staes; P. Reichelderfer,
USA
42144 Effect of processing delay,anticoagulant and assay (bDNA, RT-PCR)
on plasma HIV RNA decay
Lynn Kirstein*; i. W. Mellors; J.V. Giorgi; J.B. Margolick; J.P. Phair;
J.S.G. Montaner; A. Munoz, USA
42145 Gender differences in antiretroviral therapy received in Ontario:
A possible effect of viral load differences
Claudia Brabazon*; K.J. Logue; A. Burchell; R. Galli, Canada
42146 Formal analysis of the time dependent predictive value of HIV load and
host genetic factor on disease progression rate
Avidan U. Neumann*; L. Deutsch; L. Zhang; L. Kostrikis; D.D. Ho;
S. Wolinsky, Israel
42147 Rectal sno-strips and biopsies: A simple method to assess rectal viral load
and lymphoid architecture
Stephen Tabet*; C.L. Celum; C. Surawicz; S. Horton; H. Brar; D. Dondero;
R. Haggit, USA
42148 Cervicovaginal HIV-1 RNA Levels and Plasma Viral Load
Susan Cu Uvin*; A.M. Caliendo; T.P. Flanigan; K.H. Mayer;
C.CJ. Carpenter; R. Russo-Patterson; J. Allegra, USA
42149 Biases in the assessment of viral load reduction in HIV clinical trials
lan Marschner*; R.A. Betensky; V. Degruttola; D.R. Kuritzkes, USA
42150 Managementof antiretroviral therapy for HIV-1 Infection: Modeling
when to change therapy
Lawrence Wein, USA
42151 Retrospective and long term study of HIV and HCV RNA levels in
haemophiliacs (Grehco Study)
Anne-Marie Berthier*; I. Renard; M. Vicariot; 0. Guist'hau; R. Colimon;
P. Gueret; A.M. Ruffault, France

42152 CD4+ Cell decline despite maintenance of stable HIV-1 RNA in HIV-1
infection prior to AIDS
William A. O'Brien*; A. Bush; R.A. De Masi; A.M. Hill, USA

42153 Impact of plasma HIV RNA on CD4 change and outcome for women in
the women's interagency HIV study
Andrea Kovacs*; L. Chan; J. Bremer; W.A. Meyer; B. Weiser; M. Young;
N. Hessol, US
42154 Durability of undetectable viral load (VL) in response to antiretroviral
therapy: An assessment of immunologic and virologic parameters
Kimberly Y. Smith*; B. Sha; A. Tenorio; H.A. Kessler; J. Pottage;
G. Trenholme, USA
42155 Viral load assays and HIV-1 subtypes in European clinical trials
Veronique Michael*; 6. Anderegg; F. Campbell; A.F. Amor, Switzerland
42156 Usefulness of HIV-RNA levels for monitoring HIV-1 positive individuals
in community-based settings
Angelos Hatzakis*; Giota Toulouhi; V. Paparizos; H. Sambatakou;
T. Kordossis; A. Karafoulidou; M. Lazanas; A. Antoniadou, Greece
42157 Viral load testing in Ontario
Carol Major*; R. Remis; T. Degazio; R. Galli; S. Read; M. Fearon, Canada
42158 Evaluation of two second generation HIV-1 viral load assays with
improved lower detection limits
Richard Galli*; Carol Major; G. Strunc; T. Degazio; C. Swantee; M. Fearon,
Canada
42159 The roles of HIV RNA levels and CD4 counts when assessing all-cause
mortality
Veronica Miller*; Caroline Sabin; C. Rottman; A.N. Phillips; A.M. Hill;
T. Leder; P. Gute; S. Staszewski, Germany
42160 Development of quantitative assays using the 5' nuclease technology
Shirley Kwok*; S.D. Lu; S. Tsang; S. Y. Kao; J. Weiss, USA
42161 Changes in viral load during acute respiratory infections in HIV-infection
Alicia Villar*;. Pinilla; P. Labarga; F. Anton; A. Elena, Spain
42162 Comparison of NucliSens and Roche Monitor assays for HIV-1 RNA
quantitation
John Dyer*; C. Pilcher; R. Shepard;J. Schock;].]. Eron; S.A. Fiscus,
Australia
42163 The contributions of assay variation and biological variation to the
variability of HIV RNA measurements in serially collected clinical
specimens
Donald Brambilla*; Robert Coombs; J.W. Bremer; P.S. Reichelderfer;
L. Kalish; D.E. Shapiro, USA
NOTES

CONFERENCE WORKBOOK

193